Larvol Delta - VT3996301-Nanatinostat-Plus-Valganciclovir-in-Patients-with-Advanced-EBV-Solid-Tumors-and-in-Combination-with-Pembrolizumab-in-EBV-RMNPC

Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe

Keytruda (pembrolizumab) - Merck (MSD)

nanatinostat (VRx-3996) - Viracta Therap

http://clinicaltrials.gov/ct2/show/NCT05166577

Sep 21, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next